Creation of a pocket for intracorneal riboflavin instillation using the femtosecond laser (IntraLase, Advanced Medical Optics) appears to be a safe and effective method for assisting cornea collagen cross-linking.
Creation of a pocket for intracorneal riboflavin instillation using the femtosecond laser (IntraLase, Advanced Medical Optics) appears to be a safe and effective method for assisting cornea collagen cross-linking, said A. John Kanellopoulos, MD, at Refractive Surgery Subspecialty Day.
The technique, which Dr. Kanellopoulos has dubbed the "i-cornea tan," involves use of the laser to cut a 7-mm pocket at 100 µm corneal depth with a side cut of just 5 degrees. Then an air cannula is introduced into the pocket to instill the riboflavin 0.1% solution prior to UVA irradiation.
Dr. Kanellopoulos, medical director, Laservision Institute, Athens, Greece, reported using this procedure in 10 keratoconic eyes. Outcomes for mean reduction in keratometry and sphere achieved were comparable to those observed in eyes treated with the standard crosslinking technique. However, the new procedure was much more comfortable and associated with more rapid visual rehabilitation, he said. Endothelial cell counts were unchanged, and Dr. Kanellopoulos pointed out that the pocket creation does not have any adverse biomechanical effect on the cornea due to the minimal side cut.
"This technique provides a method for targeted delivery of riboflavin into the cornea at the depths where it is needed for crosslinking, and has several other advantages for the patient. Our initial experience must be validated with further studies and longer follow-up," Dr. Kanellopoulos said. "However, we believe this method has the potential to become the paradigm for preventing corneal transplantation in eyes with corneal ectasia."
AAO 2024: Transient vision loss with Alexander Fein, MD
October 21st 2024Alexander Fein, MD, spoke with the Eye Care Network to share how to approach a patient presenting with transient vision loss, what this type of vision loss can mean, and what additional testing might be needed to determine the best plan for care.
AAO 2024: Optimal pupil size reduction percentage for near vision improvement in presbyopia
October 21st 2024Jennifer Loh, MD, shared insights from on her presentation at the American Academy of Ophthalmology meeting in Chicago on the effects of CSF-1, which is the lowest effective concentration of pilocarpine approved in the United States.